Vaxcyte
PCVX
PCVX
106 hedge funds and large institutions have $1.09B invested in Vaxcyte in 2022 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 47 increasing their positions, 20 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 8 → 8 (0)
0.33% less ownership
Funds ownership: 88.54% → 88.21% (-0.33%)
10% less capital invested
Capital invested by funds: $1.2B → $1.09B (-$118M)
Holders
106
Holding in Top 10
8
Calls
$5.36M
Puts
$4K
Top Buyers
| 1 | +$17.9M | |
| 2 | +$10.3M | |
| 3 | +$10.1M | |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$9.97M |
| 5 |
BlackRock
New York
|
+$8.39M |
Top Sellers
| 1 | -$31.5M | |
| 2 | -$22.1M | |
| 3 | -$11.4M | |
| 4 |
TGA
TPG GP A
Fort Worth,
Texas
|
-$8.44M |
| 5 |
PBPIA
Pivotal bioVenture Partners Investment Advisor
San Francisco,
California
|
-$6.08M |